App-Quantinova.ai

Renal Denervation With Symplicity Spyral Catheter in the Global Symplicity Registry: Safety and Efficacy at 3 Years

Michael Bohm - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Cardiac Autonomic Nerve Stimulation Improves Hemodynamics and Clinical Status in Advanced Heart Failure Patients

Christian Marin y Kall - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Advanced heart failure

N/A

Tricuspid Valve-in-Valve and Bioprosthetic Surgical Tricuspid and Pulmonic Valve Degeneration: Lessons From Imaging and Histopathology

Stephanie Sellers - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Impact of Coronary Artery Bypass History in Patients Undergoing Chronic Total Occlusion-Percutaneous Coronary Intervention: Procedural and Clinical Outcomes from the Registry of CrossBoss and Hybrid Procedures in France, the Netherlands, Belgium, and United Kingdom (RECHARGE)

Simone Budassi - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Efficacy and Safety of the NovaCross Microcatheter for Chronic Total Occlusions: An Expanded Safety Study

Simon Walsh - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Diagnostic Performance of Fractional Flow Reserve and Instantaneous Wave-Free Ratio in LAD and Non-LAD: Results of Iberian-Dutch-English (IDEAL) LAD Study

Yuetsu Kikuta - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for Three Vessel Disease

Norihiro Kogame - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Comparison Between the Diagnostic Performance of Quantitative Flow Ratio and Myocardial Perfusion Imaging for Detecting Myocardial Ischemia

Pepijn van Diemen - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

The Immediate Physiological Impact of Transcatheter Aortic Valve Replacement on Central Aortic Pressure in Patients With Severe Aortic Stenosis

Michael Michail - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

In-Hospital Outcome of Endovascular Intervention Versus Surgical Revascularization Among Patients With Atrial Fibrillation

Homam Moussa Pacha - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Peripheral artery disease

N/A

In-Hospital Outcomes and Trends of Limb Revascularization Procedures in Patients With and Without Atrial Fibrillation

Homam Moussa Pacha - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial

Chun-Chin Chang - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Everolimus

Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Hemodynamic Analysis of New Version Mirage Bioresorbable Scaffold and Metallic Ultimaster Stent: A New Era Begins With Shear Stress Analysis in Stent Assessment

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

MIRAGE syndrome

N/A

Overexpansion of Thin-Strut BRS an a Lesion Model: In Vitro Insights on Recoil and Mechanical Integrity

Shengjie Lu - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Everolimus

Implantation of Thin-Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With De Novo Coronary Artery Lesions: 2-Year Clinical and 6-Month Imaging Outcomes of the MeRes-1 Extend Trial

Alexandre Abizaid - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary artery lesions

sirolimus

The Impact of Atherosclerotic Plaque Type on Strut Penetration and Local Hemodynamics in Bioresorbable Scaffolds

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Everolimus

Preclinical Evaluation of a Novel Thin-Strut PLLA Bioresorbable Scaffold in Porcine Coronary Artery at 6-Month Follow-Up

Kuniaki Takahashi - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Everolimus

Evaluation and Validation of the Beckman-Coulter ACCESS High Sensitivity Troponin I Assay using a Novel Single Cut-Off Strategy for an Early Rule Out Acute Coronary Syndrome Protocol (ACS-ERP) in a Real-World Emergency Department Population

Kalaivani Mahadevan - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Coronary Collateral Regression Following Chronic Total Occlusion Percutaneous Coronary Intervention

Novalia Sidik - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Filters

45280 Abstracts